HISAMITSU PHARMACEUTICAL CO.,INC. (4530)

Market cap
¥514.8B
P/E ratio
19.9x
Hisamitsu Pharmaceutical manufactures and sells over-the-counter medications like allergy treatments, operating globally through subsidiaries in the US, Europe, and Asia.
Period EndMarketable securities, current (Million JPY)YoY (%)
Feb 28, 20269,779-33.01%
Feb 28, 202514,598+13.50%
Feb 29, 202412,862-12.59%
Feb 28, 202314,714+11.97%
Feb 28, 202213,141-39.56%
Feb 28, 202121,743-37.66%
Feb 29, 202034,878+66.51%
Feb 28, 201920,946+41.92%
Feb 28, 201814,759-54.96%
Feb 28, 201732,767+6.06%
Feb 29, 201630,895+22.64%
Feb 28, 201525,192
AI Chat